898 898 8787

Beyond the Liver Function Test: How AI Could Improve Liver Disease Detection

Health

Beyond the Liver Function Test: How AI Could Improve Liver Disease Detection

author
Medically Reviewed ByDr. Mayanka Lodha Seth
Written By
Sheena Mehta
Last Edited BySheena MehtaSep 10, 2026
share
https://myhealth-redcliffelabs.redcliffelabs.com/media/blogcard-images/None/8cbf3c35-8691-4540-8ea4-99e41f03f618.webp
share

Overview 

  1. Learn what a Liver Function Test (LFT) checks and what its results can tell you about liver health.
  2. Understand why a normal LFT does not always rule out fatty liver or liver fibrosis.
  3. Discover how FIB-4 uses routine blood test results to help assess the risk of advanced liver fibrosis.
  4. Explore how AI can analyze multiple health and laboratory markers to support earlier and more targeted liver disease detection.
  5. Understand the role of LFT, FIB-4, imaging, and AI and why these tools work best as complementary approaches.
  6. Learn what further assessment may be considered when liver disease risk remains despite a normal LFT

You get a routine health check, and your liver function test comes back within the reported range. Does that mean your liver is completely healthy? Not necessarily. An LFT can provide important clues about liver injury and function, but it does not directly measure liver fat or fibrosis. This is where newer approaches are becoming interesting. Researchers are exploring whether tools such as FIB-4 and artificial intelligence can make better use of routine blood-test data and help identify people who may need further liver assessment. So, what can an LFT tell you, what can it miss, and how could AI help make sense of what happens next? 

What Can a Liver Function Test Tell You?

A liver function test (LFT) is a group of blood tests that provides information about different aspects of liver health.

Depending on the panel, it may include:

  • ALT (Alanine Aminotransferase): An enzyme mainly found in the liver; elevated levels can indicate liver-cell injury.
  • AST (Aspartate Aminotransferase): An enzyme found in the liver and other tissues; elevated levels can occur with liver injury.
  • ALP (Alkaline Phosphatase): An enzyme linked to the liver and bile ducts, but also found in bones.
  • GGT (Gamma-Glutamyl Transferase): An enzyme associated with the liver and bile ducts; results are interpreted with other tests.
  • Bilirubin: A waste product processed by the liver and removed through bile.
  • Albumin: A protein made by the liver that helps maintain fluid balance.
  • Total Protein: Measures major blood proteins, including albumin and globulins.

An LFT offers important clues about liver health, but it does not directly measure liver fat or fibrosis. 

Also read: 

https://redcliffelabs.com/myhealth/food-and-nutrition/fatty-liver-diet-foods-to-include-foods-to-avoid-and-lifestyle-changes/

Why Liver Function Testing Matters in Fatty Liver Disease 

MASLD can range from liver fat accumulation without significant inflammation to MASH, which involves inflammation and liver injury. Some people may develop fibrosis, and advanced fibrosis can progress to cirrhosis. In people with cirrhosis, the risk of liver cancer is higher. 

The important point is not that everyone with metabolic risk has advanced liver disease. Rather, identifying people at higher risk allows appropriate assessment before significant liver damage develops.

Can a Normal LFT Rule Out Liver Disease? 

A normal ALT or AST does not necessarily rule out MASLD or liver fibrosis. Liver enzymes are markers of liver injury, but they do not directly measure the amount of fat in the liver or the extent of scarring.

So, what other tools can help assess liver disease risk? 

What Does FIB-4 Add to a Liver Function Test?

One way of getting more information from routine blood tests is the FIB-4 score.

FIB-4 uses four routinely available pieces of information:

Age + AST + ALT + platelet count

Unlike an LFT, which provides individual laboratory measurements, FIB-4 combines several variables into a single fibrosis-risk estimate. 

A low-risk FIB-4 result may help identify people at a lower likelihood of advanced fibrosis, while an indeterminate or higher-risk result may lead to further assessment. Interpretation depends on age, clinical context, and the guideline being followed. 

How Could AI Make More Sense of Routine Liver Tests?

AI is being studied to analyze routine laboratory and clinical information, as well as newer biological signals that conventional tests may not capture. 

One emerging area is fragmentomics, which studies tiny DNA fragments circulating in the blood. Researchers are exploring whether their patterns can help identify liver fibrosis and cirrhosis earlier.

AI models are also being studied to analyze routine markers such as ALT, AST, blood glucose, triglycerides, cholesterol, and platelets together, rather than looking at one result alone. 

The aim is not to replace blood tests, but to use existing data more effectively and identify people who may need further liver assessment. These approaches are still being researched and are not currently standard replacements for conventional liver testing.  

Can AI Replace a Liver Function Test? 

AI may help analyze laboratory, clinical, and imaging data, but it is not a standalone replacement for a liver function test or other appropriate liver assessments. 

Healthcare professionals still need to consider the person's:

  • Symptoms and medical history
  • Medication and supplement use
  • Alcohol exposure
  • Diabetes and metabolic health
  • Blood test patterns
  • Imaging findings
  • Other possible causes of liver abnormalities
  • Previous test results and trends

The different tools have different roles:

  • LFT: Provides information about liver injury and function
  • FIB-4: Helps estimate fibrosis risk
  • Imaging: Helps assess liver fat or structural changes
  • AI: May help analyze multiple data points and identify patterns

AI is therefore more likely to complement existing liver tests than replace them.

Indian Research: Where Could AI Fit Into Liver Testing?

Researchers at the Institute of Liver and Biliary Sciences (ILBS), New Delhi, and collaborating institutions evaluated machine-learning models for predicting advanced liver fibrosis in 452 patients with biopsy-proven MASLD. The best-performing model achieved 84% accuracy in the study population, showing the potential of routinely available clinical and biochemical information to enable more targeted risk assessment. But these models need further validation before routine use.

The research is promising, but AI-based liver assessment is not yet a replacement for established tests or clinical evaluation.

Related Link: https://pubmed.ncbi.nlm.nih.gov/41550712/  

What If Your LFT Is Normal?

A normal LFT can be reassuring, but it does not rule out fatty liver or liver fibrosis on its own. If you have risk factors such as type 2 diabetes, excess weight, high triglycerides, or previously detected fatty liver, your doctor may consider:

  • FIB-4
  • Ultrasound
  • FibroScan or other elastography
  • Other tests based on individual risk

The right combination of tests depends on your health history and individual risk. 

What Happens After Your Liver Function Test?

Getting a liver function test is only the first step. Understanding the results and tracking changes over time can make the information more useful.

At Redcliffe Labs, every test comes with 4X Value Benefits:

  1. Smart Reports with Health Trends & Actionable Insights

Easy-to-read health summaries, health scores,s and trend tracking help you understand how your results change over time.

  1. Expert-Led Report Consultation

Experts help explain your report, discuss potential areas of concern, and clarify what your results may mean.

  1. AI Health Assistant for Everyday Health Guidance

An AI-powered health assistant can help answer health-related questions and clarify general doubts.

  1. Goal-Based Personalized Improvement Plans

Personalized lifestyle and diet guidance can support healthier habits based on individual goals and risk factors.

The goal is not simply to receive a test report, but to understand what your results mean and what steps may be appropriate next.  

Conclusion

AI is opening up new possibilities for liver disease detection, but it does not make the liver function test obsolete. A liver function test remains an important part of assessing liver health, but it does not provide the complete picture on its own. FIB-4, imaging and emerging AI-based approaches may add further information when additional assessment is needed. 

The future may not be about replacing the liver function test with AI, but about combining laboratory, clinical and imaging information to identify people who may benefit from earlier and more targeted assessment. 

FAQs

Can a liver function test detect fatty liver?

A liver function test can provide clues about liver injury, but it cannot directly measure liver fat. Some people with fatty liver disease may have normal ALT and AST levels. If risk factors such as diabetes, excess weight, or abnormal triglycerides are present, a doctor may recommend additional assessment, such as imaging or fibrosis risk evaluation.

What does a liver function test show?

An LFT measures several blood markers that provide information about liver health. Depending on the panel, it may include ALT, AST, ALP, GGT, bilirubin, albumin, and total protein. These results can help identify patterns suggesting liver-cell injury, bile-flow problems, or changes associated with reduced liver function. Still, they do not provide a complete diagnosis on their own.

Can a normal liver function test rule out liver fibrosis?

No. A normal liver function test does not completely rule out liver fibrosis. Liver enzymes mainly indicate liver-cell injury and may remain within the reported range even when fibrosis is present. Depending on individual risk, healthcare professionals may use tools such as FIB-4, elastography, or imaging to assess the likelihood of significant liver fibrosis.

What is FIB-4, and how is it related to liver function tests?

FIB-4 is a non-invasive score used to estimate the risk of advanced liver fibrosis. It combines age, AST, ALT, and platelet count, using information often available from routine blood tests. Unlike a liver function test, which reports individual markers, FIB-4 combines these values into an estimate of fibrosis risk.

Can artificial intelligence detect liver disease from blood tests?

Researchers are studying artificial intelligence to analyze combinations of blood-test results, clinical information, and other health data to identify patterns associated with liver disease. However, AI cannot currently be considered a standalone diagnostic test for fatty liver or fibrosis. Established tests, imaging,g and clinical assessment remain important when evaluating possible liver disease.

Can AI replace a liver function test?

No. Artificial intelligence is currently being explored as a decision-support tool rather than a replacement for a liver function test. AI may help analyze multiple laboratory, clinical, or imaging findings together, while a liver function test continues to provide important information about liver injury and aspects of liver function.

What should you do if your liver function test is normal but you have liver disease risk factors?

A normal liver function test can be reassuring, but it does not completely exclude fatty liver or fibrosis. If you have risk factors such as type 2 diabetes, excess weight, high triglycerides, or previously detected fatty liver, discuss your results with a healthcare professional to determine whether additional assessment is appropriate.

Leave a comment

Explore Our Services

Quick access to popular pathology tests, categories, and health packages across India

Consult Now

Share MyHealth Blog